Hamlet Pharma achieves full funding from the European Commission
In a recent evaluation of Hamlet Pharma, the European Commission concluded that Hamlet Pharma’s bladder cancer project has delivered exceptional results with immediate or potential impact. The company was commended by the European Commission for the progress made during the receipt of the EU Horizon 2020 grant in the EIC Accelerator program. The European Commission concluded that the project...
Taggar: hamlet, pharma, achieves
Läs hela artikeln på Dagens industriRelaterade nyheter
- Kallelse till extra bolagsstämma i Hamlet Pharma AB (publ)
- Hamlet Pharma och SelectImmune Pharma går samman för att skapa ett nydanande läkemedelsbolag med en bred och stark portfölj av projekt för...
- Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the...